Provided by Tiger Trade Technology Pte. Ltd.

Vertex Pharmaceuticals

522.81
-3.9200-0.74%
Post-market: 522.810.00000.00%19:58 EDT
Volume:1.15M
Turnover:601.42M
Market Cap:132.65B
PE:30.43
High:529.72
Open:525.26
Low:522.74
Close:526.73
52wk High:560.25
52wk Low:392.50
Shares:253.72M
Float Shares:253.72M
Volume Ratio:1.29
T/O Rate:0.45%
Dividend:- -
Dividend Rate:- -
EPS(TTM):17.18
EPS(LYR):15.32
ROE:23.54%
ROA:11.93%
PB:6.55
PE(LYR):34.13

Loading ...

May 14, 2026

Employee Stock Ownership

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
May 14, 2026

Employee Stock Ownership

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
May 14, 2026

Employee Stock Ownership

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
May 14, 2026

Employee Stock Ownership

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
May 14, 2026

Employee Stock Ownership

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
May 13, 2026

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
May 13, 2026

Major Issues Report

Form 8-K - Current report
May 12, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 06, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 05, 2026

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 05, 2026

Major Issues Report

Form 8-K - Current report
May 04, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 01, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Apr 30, 2026

Beneficial Ownership Change

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
Apr 30, 2026

Major Issues Report

Form 8-K - Current report
Apr 02, 2026

Correspondence

Form CORRESP - Correspondence
Apr 01, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 31, 2026

Major Issues Report

Form 8-K - Current report
Mar 27, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 13, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities